27328333|t|Uveitis in children
27328333|a|The review provides updates on novel risk markers for the development of pediatric inflammatory uveitis and a severe disease course, on treatment of refractory disease, and on the measurement of visual outcomes. There are several new genetic markers, biomarkers, and clinical factors that may influence a child's uveitis disease course. It is important to identify children at risk for poor visual outcomes and who are refractory to traditional therapy. Racial disparities have recently been reported. We describe agents of potential benefit. In addition, we discuss the importance of patient reported outcomes in this population. Uveitis can lead to vision-threatening complications. Timely and aggressive treatment of children identified to be at risk for a severe uveitis course may lead to improved outcomes.
27328333	0	7	Uveitis	T047	C0042164
27328333	11	19	children	T100	C0008059
27328333	51	56	novel	T080	C0205314
27328333	57	69	risk markers	T080	C1519104
27328333	78	89	development	T169	C1527148
27328333	93	102	pediatric	T080	C1521725
27328333	103	123	inflammatory uveitis	T047	C0042164
27328333	130	151	severe disease course	T046	C0242656
27328333	156	165	treatment	T061	C0087111
27328333	169	187	refractory disease	T033	C1514815
27328333	200	211	measurement	T169	C0242485
27328333	215	230	visual outcomes	T169	C1274040
27328333	254	269	genetic markers	T045	C0017393
27328333	271	281	biomarkers	T201	C0005516
27328333	287	295	clinical	T080	C0205210
27328333	296	303	factors	T169	C1521761
27328333	325	332	child's	T100	C0008059
27328333	333	340	uveitis	T047	C0042164
27328333	341	355	disease course	T046	C0242656
27328333	385	393	children	T100	C0008059
27328333	397	401	risk	T078	C0035647
27328333	406	426	poor visual outcomes	T169	C1274040
27328333	439	449	refractory	T169	C0332325
27328333	453	472	traditional therapy	T061	C3650840
27328333	474	492	Racial disparities	T033	C0243095
27328333	512	520	reported	T170	C0684224
27328333	534	540	agents	T120	C0450442
27328333	544	561	potential benefit	T081	C0814225
27328333	605	630	patient reported outcomes	T170	C2987124
27328333	639	649	population	T101	C0030705
27328333	651	658	Uveitis	T047	C0042164
27328333	671	703	vision-threatening complications	T046	C0009566
27328333	705	736	Timely and aggressive treatment	T061	C0087111
27328333	740	748	children	T100	C0008059
27328333	769	773	risk	T078	C0035647
27328333	780	801	severe uveitis course	T046	C0242656
27328333	814	831	improved outcomes	T169	C1274040